The association of anti-CCP antibodies with disease activity in rheumatoid arthritis

Rheumatology International

Volumn 28, Issue 10, 2008, Pages 965-970

  Serdaroğlu, Münevver ^a   Çakırbay, Haşim ^a   Değer, Orhan ^a   Cengiz, Sevil ^a   Kul, Sibel ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Anti CCP antibodies; Disease activity; Radiological erosions; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HLA DR3 ANTIGEN; RHEUMATOID FACTOR;

ADULT; ANTIBODY DETECTION; ARTICLE; BONE EROSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBROMYALGIA; GENOTYPE; HLA SYSTEM; HUMAN; IMAGE ANALYSIS; JOINT RADIOGRAPHY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 47249125340     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0570-3     Document Type: Article

References (39)

1. Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903-911
2. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK (1984) Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27:864-872
3. Goodson N (2002) Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 14:115-120
4. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
5. Vallbracht I, Helmke K (2005) Additional diagnostic and clinical value of anti-cylic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Autoimmunity Rev 4:389-394
6. Mottonen TT (1988) Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 47:648-653
7. van der Heijde DM (1995) Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34 (Suppl 2):1-8
8. Gough AK, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23-27
9. Olsen NJ, Stein CM (2004) New drug for rheumatoid arthritis. N Engl J Med 350:2167-2179
10. Eggeland T, Munthe E (1983) The role of the laboratory in rheumatology, rheumatoid factors. Clin Rheum Dis 9:135-160
11. Smolen JS (1996) Autoantibodies in rheumatoid arthritis. In: van Venrooij WJ, Maini RN, (eds) Manual of biological markers of disease, Section C1.1/1-C1.1/18. Kluwer, Dordrecht
12. Thorsteinsson J, Bjfrnsson OJ, Kolbeinsson A, Allander E, Sigfusson N, Olafsson O (1975) A population study of rheumatoid factor in Iceland. A 5 year follow-up of 50 women with rheumatoid factor (RF). Ann Clin Res 7:183-194
13. Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL et al (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50:709-715
14. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741-2749
15. Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A et al (2003) Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62:120-126
16. Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085-1089
17. van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E et al (2004) Association between HLA class IIgenes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 50:2113-2121
18. Emery P (1994) The optimal management of early rheumatoid disease: the key to preventing disability. Br J Rheumatol 33:765-768
19. LIndovist E, Eberhardt K, Bendtzen K et al (2005) Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 64:196-201
20. VIsser H (2005) Early diagnosis of rheumatoid arthritis. Best Pract Res Clin Rheumatol 19:55-72
21. Kaarela K, Kauppi MJ, Lehtinen KE (1995) The value of the ACR 1987 criteria in very early rheumatoid arthritis. Scand J Rheumatol 24:279-281
22. Saraux A, Berthelot JM, Chales G, Le Henaff C, Thorel JB, Hoang S et al (2001) Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 44:2485-2491
23. van Venrooij WJ, Hazes JM, Visser H (2002) Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 60:383-388
24. Kirwan JR, Quilty B (1997) Prognostic criteria in rheumatoid arthritis: can we predict which patients will require specific anti-rheumatoid treatment? Clin Exp Rheumatol 15(Suppl 17):S15-S25
25. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155-163
26. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M, van de Putte LB, van Rijswijk MH, van Venrooij WJ, van Riel PL (2000) The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. ArthritisRheum 43:1831-1835
27. Lee DM, Schur PH (2003) Clinical utility of the anti-CCP assays in patients with rheumatic diseases. Ann Rheum Dis 62:870-874
28. DubucquoI S, Solau-GervaIs E, Lefranc D et al (2004) Evaluation of anti-citrullinatedfilagrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis 63:415-419
29. MImori T (2005) Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Intern Med 44:1112-1126
30. van Jaarsveld CHM, ter Borg EJ, Jacobs JWG, Schellekens GA, Gmeling-Meyling FHJ, van Booma-Frankfort C et al (1999) The prognostic value of the antiperinuclear factor, anticitrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 17:689-697
31. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW (2002) How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) Arthritis. Arthritis Rheum 46:357-365
32. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B (2004) BARFOT Study Group. Prediction of radiological outcome in early reumatoid arthritis in clinic paractice, role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 63:1090-1095
33. Bas S, Perneger T.V, Seitz M et al (2002) Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology 41:809-814
34. Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677-680
35. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-13. (discussIon-HLA DR)
36. Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooji WJ et al (2004) A combination of autoantibodies to cylic citrullinatedpeptide (CCP) and HLA-DRB1 locus antigens iss strogly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 6(4):R303-R308
37. Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA (2004) Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 50:400-412
38. El-Gabalawy HS, Goldbach-Mansky R, Smith D II, Arayssi T, Bale S, Gulko P, Yarboro C, Wilder RL, Klippel JH, Schumacher HR Jr (1999) Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 42:1696-1705
39. Harrison B, Thomson W, Symmons D, Ollier B, Wiles N, Payton T, Barrett E, Silman A (1999) The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis Rheum 42:2174-2183